Holtmann M H, Hadac E M, Ulrich C D, Miller L J
Center for Basic Research in Digestive Diseases, Mayo Clinic and Foundation, Rochester, Minnesota, USA.
J Pharmacol Exp Ther. 1996 Nov;279(2):555-60.
The affinity and specificity of the binding interaction between ligands and their receptors are key for appropriate hormonal regulation of target tissues. However, it is now apparent that vasoactive intestinal polypeptide (VIP) binds to the rat secretin receptor with similar affinity to that for its natural ligand, secretin (Holtmann et al., 1995). In this report, we establish that this is not a characteristic of the human secretin receptor, and use rat-human secretin receptor chimeras, site mutants and truncated receptor constructs to establish the molecular basis for this unusual binding interaction. Of note, isolated N-terminal domains of the rat secretin and the VIP receptors are capable of high affinity binding of VIP. In the recently recognized secretin family of receptors, this domain has six conserved cysteine residues and disulfide bonds that are likely important to achieve the complex conformation critical for this binding. A single acidic residue (Asp98) present in the rat secretin receptor appears to be critical, because a site-mutant changing this to the polar, but uncharged residue present in that position in the human receptor (Asn) eliminates the high affinity binding of VIP. Of interest, a previously identified critical basic residue in VIP (Lys15) provides a candidate for charge-pairing with this residue, potentially aligning the peptide ligand in a nonproductive orientation within this receptor.
配体与其受体之间结合相互作用的亲和力和特异性是靶组织进行适当激素调节的关键。然而,现在很明显,血管活性肠肽(VIP)与大鼠促胰液素受体的结合亲和力与其天然配体促胰液素相似(Holtmann等人,1995年)。在本报告中,我们证实这并非人类促胰液素受体的特性,并利用大鼠-人类促胰液素受体嵌合体、位点突变体和截短的受体构建体来确定这种异常结合相互作用的分子基础。值得注意的是,大鼠促胰液素和VIP受体的分离N端结构域能够与VIP进行高亲和力结合。在最近被认识的促胰液素受体家族中,该结构域有六个保守的半胱氨酸残基和二硫键,它们可能对实现这种结合至关重要的复杂构象很重要。大鼠促胰液素受体中存在的一个单一酸性残基(Asp98)似乎至关重要,因为将其突变为人类受体中该位置存在的极性但不带电荷的残基(Asn)的位点突变体消除了VIP的高亲和力结合。有趣的是,VIP中先前确定的一个关键碱性残基(Lys15)为与该残基进行电荷配对提供了一个候选者,可能使肽配体在该受体内以非生产性方向排列。